Impact of glucagon‐like peptide‐1 receptor agonists on adiponectin concentrations: a meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14855 ◽

2021 ◽

Author(s):

Luis E. Simental‐Mendía ◽

Adriana Sánchez‐García ◽

Enrique Linden‐Torres ◽

Mario Simental‐Mendía

Keyword(s):

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review4 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review2 ◽

2019 ◽

Author(s):

Per Wändell

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review5 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review1 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Effect of glucagon-like peptide-1 receptor agonists on circulating levels of leptin and resistin: a meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.108899 ◽

2021 ◽

pp. 108899

Author(s):

Luis E. Simental-Mendía ◽

Adriana Sánchez-García ◽

Enrique Linden-Torres ◽

Mario Simental-Mendía

Keyword(s):

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Circulating Levels

Download Full-text

Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists’ treatment: a meta-analysis of randomized controlled trials

Endocrine ◽

10.1007/s12020-014-0361-4 ◽

2014 ◽

Vol 48 (1) ◽

pp. 107-115 ◽

Cited By ~ 84

Author(s):

Bin Su ◽

Hui Sheng ◽

Manna Zhang ◽

Le Bu ◽

Peng Yang ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Bone Fractures ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials

Acta Diabetologica ◽

10.1007/s00592-017-1049-z ◽

2017 ◽

Vol 54 (11) ◽

pp. 1069-1071

Author(s):

Ilaria Dicembrini ◽

Besmir Nreu ◽

Alessia Scatena ◽

Francesco Andreozzi ◽

Giorgio Sesti ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review1 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review3 ◽

2019 ◽

Author(s):

Luis M. Ruilope

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials

International Journal of Cardiology ◽

10.1016/j.ijcard.2017.03.163 ◽

2017 ◽

Vol 240 ◽

pp. 414-421 ◽

Cited By ~ 24

Author(s):

Matteo Monami ◽

Stefania Zannoni ◽

Laura Pala ◽

Antonio Silverii ◽

Francesco Andreozzi ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text